In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US
Executive Summary
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.
You may also be interested in...
UK’s NICE Backs Two Microsphere Products For Liver Cancer But Says No To Another
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
Exec Chat: Signifier Medical Investing In ‘Daytime-Only Treatments’ And Diagnostics For Sleep Apnea
The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.
Cantel Medical Snapped Up By Steris For $3.6Bn
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.